Magnetic detection is arguably the most used sensing technology in our daily life and has proven to be a superior option in many applications: e.g. automotive and mobile communication. In the healthcare, however, this technology is yet to be utilised to its full potential. MD&I department develops and valorises medical devices based upon electromagnetic principles based upon nanoscale physics. Specifically, the nonlinear magnetic response of magnetic nanoparticles to a low external magnetic field (<30 mT) that follows a combination of Néel and Brownian relaxation. This technology shows great promise as an efficient replacement more invasive and expensive procedures.
Principal investigator: Dr. Ir. Lejla Alic
Magnetic detection technologies developed by MD&I intends to optimise the interaction between individual magnetic tracers and sensing devices. Magnetic differential magnetometry principle, referred to as DiffMag, relies on a patented nonlinear magnetic principle specifically assessing magnetic tracer without influence of its environment.
Metastatic lymph nodes (LN) are one of the most important prognostic factors for cancer treatment stratification. Currently, the main options to identify the lymphatic status involves perioperative sentinel lymph node (SLN) procedure facilitated by clinical tracers: e.g. radioisotopes, fluorescence tracers, magnetic tracers, or hybrid tracers. Our clinical lines aim at a complete (pre- and perioperative) magnetic procedure for localization of SLN at a variety of cancer types.